NP · Neptune Insurance Holdings Inc. Class A Common Stock
View on chartInsiders & Stakes
| FTV VII, L.P. | ▼ Sell | Open Market | 14,442,941 Shares held | 7/29/2026 | View profile |
| BSIV Hold 101, LP | ▼ Sell | Open Market | 12,620,558 Shares held | 7/29/2026 | View profile |
| Burgess Trevor R Chief Executive Officer | ▲ Buy | Grant | 2,308,672 Shares held | 9/30/2026 | View profile |
| Duffy Matthew Paul President & Chief Risk Officer | ▼ Sell | Open Market | 1,879,798 Shares held | 10/8/2026 | View profile |
| Carlon Jonathan Winant Director | ▲ Buy | Grant | 606,980 Shares held | 9/30/2026 | View profile |
| Steiner James Chief Financial Officer | ▲ Buy | Grant | 546,176 Shares held | 9/30/2026 | View profile |
| Melej Cristian A Director | ▲ Buy | Grant | 69,042 Shares held | 9/30/2026 | View profile |
| Noble David Stanley Edward Director | ▲ Buy | Grant | 43,704 Shares held | 9/30/2026 | View profile |
| Vostrizansky Michael Warren | ▲ Buy | Open Market | 23,000 Shares held | 2/20/2026 | View profile |
Transaction History
| Duffy Matthew Paul | ▼ Sell | Open Market | 53,639 | $1.5M | 10/8/2026 |
| Duffy Matthew Paul | ▼ Sell | Open Market | 30,802 | $877K | 10/8/2026 |
| Duffy Matthew Paul | ▼ Sell | Open Market | 41,392 | $1.1M | 10/6/2026 |
| Duffy Matthew Paul | ▼ Sell | Open Market | 38,537 | $1.1M | 10/2/2026 |
| Duffy Matthew Paul | ▼ Sell | Open Market | 1,200 | $34K | 10/2/2026 |
| Burgess Trevor R | ▼ Sell | Tax Withholding | 254,836 | $7.0M | 9/30/2026 |
| Burgess Trevor R | ▲ Buy | Grant | 480,544 | $0 | 9/30/2026 |
| Steiner James | ▼ Sell | Tax Withholding | 64,777 | $1.8M | 9/30/2026 |
| Steiner James | ▲ Buy | Grant | 75,288 | $0 | 9/30/2026 |
| Duffy Matthew Paul | ▼ Sell | Tax Withholding | 98,381 | $2.7M | 9/30/2026 |
| Duffy Matthew Paul | ▲ Buy | Grant | 191,896 | $0 | 9/30/2026 |
| Carlon Jonathan Winant | ▼ Sell | Tax Withholding | 6,088 | $167K | 9/30/2026 |
| Carlon Jonathan Winant | ▲ Buy | Grant | 9,568 | $0 | 9/30/2026 |
| Noble David Stanley Edward | ▲ Buy | Grant | 28,704 | $0 | 9/30/2026 |
| Melej Cristian A | ▲ Buy | Grant | 9,568 | $0 | 9/30/2026 |
| Steiner James | ▼ Sell | Other | 3,349,050 | — | 9/14/2026 |
| Steiner James | ▼ Sell | Other | 3,349,050 | — | 9/14/2026 |
| Carlon Jonathan Winant | ▼ Sell | Open Market | 50,000 | $1.6M | 9/14/2026 |
| Steiner James | ▼ Sell | Other | 400,000 | — | 9/9/2026 |
| Steiner James | ▼ Sell | Other | 400,000 | — | 9/9/2026 |
| Steiner James | ▼ Sell | Open Market | 57,012 | $1.8M | 8/13/2026 |
| Steiner James | ▼ Sell | Open Market | 42,988 | $1.3M | 8/12/2026 |
| BSIV Hold 101, LP | ▼ Sell | Open Market | 1,632,160 | $54.2M | 7/29/2026 |
| FTV VII, L.P. | ▼ Sell | Open Market | 1,867,840 | $62.0M | 7/29/2026 |
| BSIV Hold 101, LP | ▼ Sell | Open Market | 688,403 | $18.2M | 5/19/2026 |
| FTV VII, L.P. | ▼ Sell | Open Market | 787,806 | $20.8M | 5/19/2026 |
| BSIV Hold 101, LP | ▼ Sell | Open Market | 4,589,351 | $121.2M | 5/15/2026 |
| FTV VII, L.P. | ▼ Sell | Open Market | 5,252,044 | $138.7M | 5/15/2026 |
| Burgess Trevor R | ▲ Buy | Open Market | 50,000 | $935K | 3/13/2026 |
| Vostrizansky Michael Warren | ▲ Buy | Open Market | 23,000 | $494K | 2/20/2026 |
| Carlon Jonathan Winant | ▼ Sell | Other | 575,000 | — | 10/2/2025 |
| Steiner James | ▲ Buy | Open Market | 119,050 | $2.4M | 10/2/2025 |
| Steiner James | ▼ Sell | Other | 3,730,000 | — | 10/2/2025 |
| Steiner James | ▼ Sell | Other | 3,730,000 | — | 10/2/2025 |
| Carlon Jonathan Winant | ▼ Sell | Other | 4,599,000 | — | 10/2/2025 |
| Carlon Jonathan Winant | ▼ Sell | Other | 4,599,000 | — | 10/2/2025 |
| Carlon Jonathan Winant | ▼ Sell | Other | 511,000 | — | 10/2/2025 |
| Carlon Jonathan Winant | ▼ Sell | Other | 511,000 | — | 10/2/2025 |
| Carlon Jonathan Winant | ▼ Sell | Other | 575,000 | — | 10/2/2025 |
| Carlon Jonathan Winant | ▲ Buy | Grant | 73,500 | $0 | 10/2/2025 |
| Duffy Matthew Paul | ▼ Sell | Other | 1,160,000 | — | 10/2/2025 |
| Duffy Matthew Paul | ▼ Sell | Other | 1,160,000 | — | 10/2/2025 |
| Melej Cristian A | ▼ Sell | Other | 20,000 | — | 10/2/2025 |
| Duffy Matthew Paul | ▲ Buy | Grant | 791,853 | $0 | 10/2/2025 |
| Melej Cristian A | ▼ Sell | Other | 20,000 | — | 10/2/2025 |
| Melej Cristian A | ▲ Buy | Grant | 39,474 | $0 | 10/2/2025 |
| Steiner James | ▲ Buy | Grant | 535,665 | $0 | 10/2/2025 |
| Burgess Trevor R | ▼ Sell | Other | 25,039,000 | — | 10/2/2025 |
| Burgess Trevor R | ▼ Sell | Other | 25,039,000 | — | 10/2/2025 |
| Burgess Trevor R | ▼ Sell | Other | 25,039,000 | — | 10/2/2025 |
| Burgess Trevor R | ▼ Sell | Other | 17,885,000 | — | 10/2/2025 |
| Burgess Trevor R | ▼ Sell | Other | 17,885,000 | — | 10/2/2025 |
| Burgess Trevor R | ▼ Sell | Other | 17,885,000 | — | 10/2/2025 |
| Burgess Trevor R | ▼ Sell | Other | 511,000 | — | 10/2/2025 |
| Burgess Trevor R | ▼ Sell | Other | 511,000 | — | 10/2/2025 |
| Burgess Trevor R | ▼ Sell | Other | 511,000 | — | 10/2/2025 |
| Burgess Trevor R | ▲ Buy | Grant | 1,982,964 | $0 | 10/2/2025 |
| Carlon Jonathan Winant | ▲ Buy | Open Market | 5,000 | $100K | 10/2/2025 |
| Burgess Trevor R | ▲ Buy | Open Market | 50,000 | $1.0M | 10/2/2025 |
| FTV VII, L.P. | ▼ Sell | Open Market | 678,019 | $12.7M | 10/1/2025 |
| BSIV Hold 101, LP | ▼ Sell | Open Market | 820,123 | $15.4M | 10/1/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Neptune Insurance Q3 Earnings Preview Amid Analyst Adjustments
Neptune Insurance is preparing to release its third-quarter financial results, with analysts watching for growth in policies in force. Wells Fargo recently lowered its price target to $34 while maintaining an overweight rating. The stock currently offers a 5.68% dividend yield, though its high trailing P/E ratio suggests investors are pricing in significant future growth expectations.
Neptune Insurance Q3 Earnings Preview Amid Analyst Adjustments. Neptune Insurance is preparing to release its third-quarter financial results, with analysts watching for growth in policies in force. Wells Fargo recently lowered its price target to $34 while maintaining an overweight rating. The stock currently offers a 5.68% dividend yield, though its high trailing P/E ratio suggests investors are pricing in significant future growth expectations.